Evidence that transcription alterations for genes associated with neurodegeneration—with the exception of MAPT—are not common drivers of gliomas was confirmed in another study, suggesting an important role of TAU in slowing down or preventing the clinical evolution of these tumors [131]. Here, MAPT is linked to central nervous system cancer.